Selective Antineoplastic Potential of Fractionated Caribbean Native Ganoderma Species Extracts on Triple-Negative Breast Cancer Cells
Open Access
- 1 July 2024
- journal article
- research article
- Published by MDPI AG in Pharmaceuticals
- Vol. 17 (7) , 864
Abstract
Triple-negative breast cancer (TNBC) is an aggressive subtype characterized by the absence of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor type 2 expression. It is known for its high malignancy, invasiveness, and propensity for metastasis, resulting in a poor prognosis due to the absence of beneficial therapeutic targets. Natural products derived from mushrooms have gained significant attention in neoplastic therapy due to their potential medicinal properties. The therapeutic potential of Ganoderma lucidum in breast cancer has been highlighted by our group, suggesting its use as an adjuvant treatment. The present study aims to assess the potential antineoplastic capacity of two Caribbean native Ganoderma species found in Puerto Rico, Ganoderma multiplicatum (G. multiplicatum) and Ganoderma martinicense (G. martinicense). Antiproliferative studies were conducted via cell viability assays after cultivation, harvesting, and fractionation of both species. The obtained results indicate that most of the fractions show some cytotoxicity against all cell lines, but 33% of the fractions (F1, F2, F7, F12) display selectivity towards cancer cell models. We demonstrate for the first time that native Ganoderma species can generate metabolites with anti-TNBC properties. Future avenues will focus on structure elucidation of the most active fractions of these Ganoderma extracts.Keywords
Funding Information
- National Institutes of Health (R16GM145488, SC3GM111171, U54GM133807, S21MD001830, 2022-33530-37064, 2022-00121, ASP231046822)
- National Institutes of Health (R16GM145488, SC3GM111171, U54GM133807, S21MD001830, 2022-33530-37064, 2022-00121, ASP231046822)
- U.S. Department of Agriculture/National Institute of Food and Agriculture/Small Business Innovation Research (R16GM145488, SC3GM111171, U54GM133807, S21MD001830, 2022-33530-37064, 2022-00121, ASP231046822)
- Puerto Rico Science, Technology & Research Trust Therapeutic Accelerator Program grant number (R16GM145488, SC3GM111171, U54GM133807, S21MD001830, 2022-33530-37064, 2022-00121, ASP231046822)
- Susan G. Komen ASPIRE (R16GM145488, SC3GM111171, U54GM133807, S21MD001830, 2022-33530-37064, 2022-00121, ASP231046822)
This publication has 56 references indexed in Scilit:
- Outcomes in breast cancer—does ethnicity matter?ESMO Open, 2023
- Traditional uses, chemical components and pharmacological activities of the genus Ganoderma P. Karst.: a reviewRSC Advances, 2020
- Molecular mechanisms of bioactive polysaccharides from Ganoderma lucidum (Lingzhi), a reviewInternational Journal of Biological Macromolecules, 2020
- Ganoderma (Lingzhi) in Traditional Chinese Medicine and Chinese Culture2019
- Prevention of Breast Cancer by Natural Phytochemicals: Focusing on Molecular Targets and Combinational StrategyMolecular Nutrition & Food Research, 2018
- Polypore diversity in North America with an annotated checklistMycological Progress, 2016
- Maximiscin Induces DNA Damage, Activates DNA Damage Response Pathways, and Has Selective Cytotoxic Activity against a Subtype of Triple-Negative Breast CancerJournal of Natural Products, 2016
- Punica granatum and its therapeutic implications on breast carcinogenesis: A reviewBioFactors, 2015
- Triple-Negative Breast CancerNew England Journal of Medicine, 2010
- Automated High-Throughput System to Fractionate Plant Natural Products for Drug DiscoveryJournal of Natural Products, 2010